Frazier Life Sciences IX, L.P. → Mirum Pharmaceuticals, Inc. MIRM

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 6.84

8,050,414 shares short · +7.9% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $24.37M

Point72 Asset Mgmt

Other 13D/G Filings on Mirum Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-01-27	SCHEDULE	Frazier Life Sciences IX, L.P.	6.80%	4,108,404	view →
2023-09-05	SC	Frazier Life Sciences IX, L.P.	—	—	view →
2022-08-18	SC	Novo Holdings A/S	—	—	view →
2020-12-22	SC	RiverVest Venture Fund IV, L.P.	—	—	view →
2020-12-18	SC	Novo Holdings A/S	—	—	view →
2020-04-29	SC	Frazier Life Sciences IX, L.P.	—	—	view →
2020-01-17	SC	Novo Holdings A/S	—	—	view →

Other Filings by Frazier Life Sciences IX, L.P.

Filed	Form	Issuer	Stake	Shares
2026-01-27	SCHEDULE	Mirum Pharmaceuticals, Inc. MIRM	6.80%	4,108,404	view →
2023-09-05	SC	Mirum Pharmaceuticals, Inc. MIRM	—	—	view →
2022-09-26	SC	Phathom Pharmaceuticals, Inc. PHAT	—	—	view →
2021-01-27	SC	Passage BIO, Inc. PASG	—	—	view →
2020-04-29	SC	Mirum Pharmaceuticals, Inc. MIRM	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →